| | Editorial Purinergic signalling in the immune system. A brief update Francesco Di Virgilio Purinergic Signal. 2007 March; 3(1): 1–3. Published online 2007 February 6. doi: 10.1007/s11302-006-9048-5.PMCID: PMC2096765 Original Papers Chemotactic activity of extracellular nucleotideson human immune cells. Daniel Myrtek and Marco Idzko Purinergic Signal. 2007 March; 3(1): 5–11. Published online 2007 March 8. doi: 10.1007/s11302-006-9032-0.PMCID: PMC2096771 Nucleotide receptor signalling and the generation of reactive oxygen species Alma N. Guerra, Monica L. Gavala, Hun Sun Chung, and Paul J. Bertics Purinergic Signal. 2007 March; 3(1): 39–51. Published online 2007 January 6. doi: 10.1007/s11302-006-9035-x.PMCID: PMC2096761 P2 receptors in macrophage fusion and osteoclast formation Thomas H. Steinberg and Jeffrey F. Hiken Purinergic Signal. 2007 March; 3(1): 53–57. Published online 2007 February 6. doi: 10.1007/s11302-006-9036-9.PMCID: PMC2096767 The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides Slavena Vylkova, Jianing N. Sun, and Mira Edgerton Purinergic Signal. 2007 March; 3(1): 91–97. Published online 2007 February 8. doi: 10.1007/s11302-006-9040-0.PMCID: PMC2096768 Adenosine and lymphocyte regulation Stefania Gessi, Katia Varani, Stefania Merighi, Eleonora Fogli, Valeria Sacchetto, Annalisa Benini, Edward Leung, Stephen Mac-Lennan, and Pier Andrea Borea Purinergic Signal. 2007 March; 3(1): 109–116. Published online 2007 January 16. doi: 10.1007/s11302-006-9042-y.PMCID: PMC2096755 From “Hellstrom Paradox” to anti-adenosinergic cancer immunotherapy Dmitriy Lukashev, Michail Sitkovsky, and Akio Ohta Purinergic Signal. 2007 March; 3(1): 129–134. Published online 2007 January 24. doi: 10.1007/s11302-006-9044-9.PMCID: PMC2096757 Adenosine in inflammatory joint diseases E. S.L. Chan, P. Fernandez, and B. N. Cronstein Purinergic Signal. 2007 March; 3(1): 145–152. Published online 2007 January 3. doi: 10.1007/s11302-006-9046-7.PMCID: PMC2096754 P2 receptors in atherosclerosis and postangioplasty restenosis Cheikh I. Seye, Qiongman Kong, Ningpu Yu, Fernando A. Gonzalez, Laurie Erb, and Gary A. Weisman Purinergic Signal. 2007 March; 3(1): 153–162. Published online 2007 February 28. doi: 10.1007/s11302-006-9047-6.PMCID: PMC2096770 CD39 and control of cellular immune responses Karen M. Dwyer, Silvia Deaglio, Wenda Gao, David Friedman, Terry B. Strom, and Simon C. Robson Purinergic Signal. 2007 March; 3(1): 171–180. Published online 2007 February 6. doi: 10.1007/s11302-006-9050-y.PMCID: PMC2096766 Reviews P1 receptors and cytokine secretion Maria P. Abbracchio and Stefania Ceruti Purinergic Signal. 2007 March; 3(1): 13–25. Published online 2007 January 30. doi: 10.1007/s11302-006-9033-z.PMCID: PMC2096764 P2 purinergic receptor modulation of cytokine production Christopher A. Gabel Purinergic Signal. 2007 March; 3(1): 27–38. Published online 2007 January 3. doi: 10.1007/s11302-006-9034-y.PMCID: PMC2096759 Activation of transcription factors by extracellular nucleotides in immune and related cell types Souzan Armstrong, Jasminka Korcok, Stephen M. Sims, and S. Jeffrey Dixon Purinergic Signal. 2007 March; 3(1): 59–69. Published online 2007 January 3. doi: 10.1007/s11302-006-9037-8.PMCID: PMC2096760 Extracellular NAD and ATP: Partners in immune cell modulation Friedrich Haag, Sahil Adriouch, Anette Braß, Caroline Jung, Sina Möller, Felix Scheuplein, Peter Bannas, Michel Seman, and Friedrich Koch-Nolte Purinergic Signal. 2007 March; 3(1): 71–81. Published online 2007 January 9. doi: 10.1007/s11302-006-9038-7.PMCID: PMC2096762 The role of P2 receptors in controlling infections by intracellular pathogens Robson Coutinho-Silva, Cristiane Monteiro da Cruz, Pedro M. Persechini, and David M. Ojcius Purinergic Signal. 2007 March; 3(1): 83–90. Published online 2007 January 12. doi: 10.1007/s11302-006-9039-6.PMCID: PMC2096763 Purinergic modulation of microglial cell activation Beáta Sperlágh and Peter Illes Purinergic Signal. 2007 March; 3(1): 117–127. Published online 2006 December 19. doi: 10.1007/s11302-006-9043-x.PMCID: PMC2096753 P2 receptors and chronic pain Kazuhide Inoue Purinergic Signal. 2007 March; 3(1): 135–144. Published online 2007 January 19. doi: 10.1007/s11302-006-9045-8.PMCID: PMC2096756 The role of P2X7 in pain and inflammation Jane P Hughes, Jonathan P Hatcher, and Iain P Chessell Purinergic Signal. 2007 March; 3(1): 163–169. Published online 2007 January 3. doi: 10.1007/s11302-006-9031-1.PMCID: PMC2096758 Article Shaping immune responses through the activation of dendritic cells’ P2 receptors Davide Ferrari, Stefania Gorini, Giulia Callegari, and Andrea la Sala Purinergic Signal. 2007 March; 3(1): 99–107. Published online 2006 August 12. doi: 10.1007/s11302-006-9024-0.PMCID: PMC2096769 Erratum Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A3 adenosine receptor ligands Diego Dal Ben, Catia Lambertucci, Sara Taffi, Sauro Vittori, Rosaria Volpini, Karl-Norbert Klotz, and Gloria Cristalli Purinergic Signal. 2007 March; 3(1): 181. Published online 2006 October 4. doi: 10.1007/s11302-006-9025-z.PMCID: PMC2096752 Corrects: Diego Dal Ben, et al. Molecular modelling study of 2-phenylethynyladenosine (PEAdo) derivatives as highly selective A3 adenosine receptor ligands. Purinergic Signal. 2006 November; 2(4): 589–594. |